These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12974147)

  • 21. Efficacy of tegaserod in chronic constipation in men.
    Fried M; Johanson JF; Gwee KA; Wagner A; Pecher E; Rueegg P
    Am J Gastroenterol; 2007 Feb; 102(2):362-70. PubMed ID: 17156137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisapride in management of chronic pediatric constipation.
    Halabi IM
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):199-202. PubMed ID: 9932855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation.
    Rao SS; Seaton K; Miller M; Brown K; Nygaard I; Stumbo P; Zimmerman B; Schulze K
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):331-8. PubMed ID: 17368232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.
    Coccorullo P; Strisciuglio C; Martinelli M; Miele E; Greco L; Staiano A
    J Pediatr; 2010 Oct; 157(4):598-602. PubMed ID: 20542295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisapride for the treatment of constipation in children: A double-blind study.
    Nurko S; Garcia-Aranda JA; Worona LB; Zlochisty O
    J Pediatr; 2000 Jan; 136(1):35-40. PubMed ID: 10636971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation.
    Quah HM; Ooi BS; Seow-Choen F; Sng KK; Ho KS
    Tech Coloproctol; 2006 Jul; 10(2):111-4. PubMed ID: 16773290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of tegaserod for functional constipation in Chinese subjects: a randomized double-blind controlled trial in a single centre.
    On Chan AO; Mo Hui W; Leung G; Hu WH; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2007 Feb; 25(4):463-9. PubMed ID: 17270002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
    Di Palma JA; Cleveland MV; McGowan J; Herrera JL
    Am J Gastroenterol; 2007 Sep; 102(9):1964-71. PubMed ID: 17573794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic constipation with cisapride and placebo.
    Müller-Lissner SA
    Gut; 1987 Aug; 28(8):1033-8. PubMed ID: 3311905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
    Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC; Barghout V; McBurney CR; Niecko TE
    Aliment Pharmacol Ther; 2005 Sep; 22(5):373-80. PubMed ID: 16128674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial.
    Ohlsson B; Truedsson M; Bengtsson M; Torstenson R; Sjölund K; Björnsson ES; Simrèn M
    Neurogastroenterol Motil; 2005 Oct; 17(5):697-704. PubMed ID: 16185308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].
    Möllenbrink M; Bruckschen E
    Med Klin (Munich); 1994 Nov; 89(11):587-93. PubMed ID: 7815986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial.
    Nurko S; Youssef NN; Sabri M; Langseder A; McGowan J; Cleveland M; Di Lorenzo C
    J Pediatr; 2008 Aug; 153(2):254-61, 261.e1. PubMed ID: 18534221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisapride for intestinal constipation.
    Aboumarzouk OM; Agarwal T; Antakia R; Shariff U; Nelson RL
    Cochrane Database Syst Rev; 2011 Jan; (1):CD007780. PubMed ID: 21249695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
    Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The administration of cisapride as an adjuvant to PEG-electrolyte solution for colonic cleansing: a double-blind randomized study.
    Katsinelos P; Pilpilidis I; Paroutoglou G; Xiarchos P; Tsolkas P; Papagiannis A; Giouleme O; Kapelidis P; Papageorgiou A; Dimiropoulos S; Eugenidis N
    Hepatogastroenterology; 2005; 52(62):441-3. PubMed ID: 15816453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and tolerability of tegaserod in patients with chronic constipation: pooled data from two phase III studies.
    Quigley EM; Wald A; Fidelholtz J; Boivin M; Pecher E; Earnest D
    Clin Gastroenterol Hepatol; 2006 May; 4(5):605-13. PubMed ID: 16678076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.